Autopsy report · NCT05718700
Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
Cause of deathFunding or business
“Sponsor decision, no safety concerns.”
Life of this trial
- Ran for about 3 years 7 months before it stopped.
- 170 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Gilead Sciences
- Sponsor type
- Industry
- Conditions
- Chronic Hepatitis D Infection
- Interventions
- Bulevirtide
- Participants
- 170
- Sites
- 53
- Countries
- Austria, France, Germany, Romania, Spain, United Kingdom
Trials that died the same way
- A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
“Sponsor's decision, no safety concerns.” - REGENETEN™ Bioinductive Implant System in Full-thickness Tears
“Sponsor decision not related to safety.” - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
“Sponsor decision; the decision is not related to any safety concern.” - (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
“Sponsor decision, not related to safety concerns” - Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS
“Sponsor decision, not for safety reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.